Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 76

1.

Valproic acid induces the expression of the Na+/I- symporter and iodine uptake in poorly differentiated thyroid cancer cells.

Fortunati N, Catalano MG, Arena K, Brignardello E, Piovesan A, Boccuzzi G.

J Clin Endocrinol Metab. 2004 Feb;89(2):1006-9.

PMID:
14764827
2.
3.
4.

Alpha-lipoic acid induces sodium iodide symporter expression in TPC-1 thyroid cancer cell line.

Choi HJ, Kim TY, Ruiz-Llorente S, Jeon MJ, Han JM, Kim WG, Shong YK, Kim WB.

Nucl Med Biol. 2012 Nov;39(8):1275-80. doi: 10.1016/j.nucmedbio.2012.08.007.

PMID:
22995901
5.
6.

Valproic acid induces apoptosis and cell cycle arrest in poorly differentiated thyroid cancer cells.

Catalano MG, Fortunati N, Pugliese M, Costantino L, Poli R, Bosco O, Boccuzzi G.

J Clin Endocrinol Metab. 2005 Mar;90(3):1383-9.

PMID:
15585556
7.

Association of low sodium-iodide symporter messenger ribonucleic acid expression in malignant thyroid nodules with increased intracellular protein staining.

Sodré AK, Rubio IG, Galrão AL, Knobel M, Tomimori EK, Alves VA, Kanamura CT, Buchpiguel CA, Watanabe T, Friguglietti CU, Kulcsar MA, Medeiros-Neto G, Camargo RY.

J Clin Endocrinol Metab. 2008 Oct;93(10):4141-5. doi: 10.1210/jc.2007-0353.

PMID:
18628528
8.

Expression of the sodium iodide symporter and thyroglobulin genes are reduced in papillary thyroid cancer.

Ringel MD, Anderson J, Souza SL, Burch HB, Tambascia M, Shriver CD, Tuttle RM.

Mod Pathol. 2001 Apr;14(4):289-96.

9.

The importance of sodium/iodide symporter (NIS) for thyroid cancer management.

Carvalho DP, Ferreira AC.

Arq Bras Endocrinol Metabol. 2007 Jul;51(5):672-82. Review.

10.

In vitro and in vivo properties of a human anaplastic thyroid carcinoma cell line transfected with the sodium iodide symporter gene.

Lee YJ, Chung JK, Shin JH, Kang JH, Jeong JM, Lee DS, Lee MC.

Thyroid. 2004 Nov;14(11):889-95.

PMID:
15671766
11.

Valproic acid inhibits growth, induces apoptosis, and modulates apoptosis-regulatory and differentiation gene expression in human thyroid cancer cells.

Shen WT, Wong TS, Chung WY, Wong MG, Kebebew E, Duh QY, Clark OH.

Surgery. 2005 Dec;138(6):979-84; discussion 984-5.

PMID:
16360381
12.

Increased expression of the sodium/iodide symporter in papillary thyroid carcinomas.

Saito T, Endo T, Kawaguchi A, Ikeda M, Katoh R, Kawaoi A, Muramatsu A, Onaya T.

J Clin Invest. 1998 Apr 1;101(7):1296-300.

13.

Retinoic acid increases sodium/iodide symporter mRNA levels in human thyroid cancer cell lines and suppresses expression of functional symporter in nontransformed FRTL-5 rat thyroid cells.

Schmutzler C, Winzer R, Meissner-Weigl J, Köhrle J.

Biochem Biophys Res Commun. 1997 Nov 26;240(3):832-8. Erratum in: Biochem Biophys Res Commun 1998 May 19;246(2):562.

PMID:
9398654
14.

Lithium as adjuvant to radioiodine therapy in differentiated thyroid carcinoma: clinical and in vitro studies.

Liu YY, van der Pluijm G, Karperien M, Stokkel MP, Pereira AM, Morreau J, Kievit J, Romijn JA, Smit JW.

Clin Endocrinol (Oxf). 2006 Jun;64(6):617-24.

PMID:
16712662
15.

Enhancement of sodium/iodide symporter expression in thyroid and breast cancer.

Kogai T, Taki K, Brent GA.

Endocr Relat Cancer. 2006 Sep;13(3):797-826. Review.

16.
17.

Rat sodium iodide symporter allows using lower dose of 131I for cancer therapy.

Mitrofanova E, Unfer R, Vahanian N, Link C.

Gene Ther. 2006 Jul;13(13):1052-6.

PMID:
16525480
18.

Expression and correlation of sodium/iodide symporter and thyroid stimulating hormone receptor in human thyroid carcinoma.

Wang ZF, Liu QJ, Liao SQ, Yang R, Ge T, He X, Tian CP, Liu W.

Tumori. 2011 Jul-Aug;97(4):540-6. doi: 10.1700/950.10410.

19.

BRAFV600E mutation, but not RET/PTC rearrangements, is correlated with a lower expression of both thyroperoxidase and sodium iodide symporter genes in papillary thyroid cancer.

Romei C, Ciampi R, Faviana P, Agate L, Molinaro E, Bottici V, Basolo F, Miccoli P, Pacini F, Pinchera A, Elisei R.

Endocr Relat Cancer. 2008 Jun;15(2):511-20. doi: 10.1677/ERC-07-0130.

20.

The sodium iodide symporter: its pathophysiological and therapeutic implications.

Spitzweg C, Morris JC.

Clin Endocrinol (Oxf). 2002 Nov;57(5):559-74. Review.

PMID:
12390328
Items per page

Supplemental Content

Support Center